Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tukysa 50 mg compresse rivestite con film
seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 50 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 9.21 mg, kalium 10.10 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
tukysa 150 mg compresse rivestite con film
seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 150 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 27.65 mg, kalium 30.29 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika
Unione Europea -
italiano -
EMA (European Medicines Agency)
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenti antineoplastici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
Unione Europea -
italiano -
EMA (European Medicines Agency)
helixate nexgen
bayer ag - octocog alfa - emofilia a - antiemorragici - trattamento e profilassi del sanguinamento in pazienti con emofilia a (deficit congenito di fattore viii). questa preparazione non contiene il fattore di von willebrand e pertanto non è indicato nella malattia di von willebrand.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
duloxetina sandoz gmbh
sandoz gmbh - duloxetina cloridrato - duloxetina cloridrato
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
gelodurat magensaftresistente weichkapseln
gebro pharma ag - eucalypti aetheroleum rectificatum (eucalyptus spp., aetheroleum), aurantii dulcis aetheroleum rectificatum (citrus × sinensis (l.) osbeck, aetheroleum), limonis aetheroleum rectificatum (citrus limon (l.) burm.f., aetheroleum), myrti folii aetheroleum rectificatum (myrtus communis l., aetheroleum) - magensaftresistente weichkapseln - destillatum 300 mg ex eucalypti aetheroleum rectificatum (eucalyptus spp., aetheroleum) et aurantii dulcis aetheroleum rectificatum (citrus × sinensis (l.) osbeck, aetheroleum) et limonis aetheroleum rectificatum (citrus limon (l.) burm.f., aetheroleum) et myrti folii aetheroleum rectificatum (myrtus communis l., aetheroleum) (66:32:1:1), rapae oleum raffinatum, kapselhülle: gelatina, glycerolum (85 per centum), sorbitolum liquidum non cristallisabile corresp. sorbitolum 35.0 - 43.1 mg, triethylis citras, natrii laurilsulfas corresp. natrium 0.06 - 0.11 mg, talcum, dextrinum, ammonii glycyrrhizas, pro capsula. - in caso di grave e cronica, sinusite e bronchite acuta e cronica - phytoarzneimittel